OR WAIT null SECS
October 02, 2026
Article
Drinking fell for the first time since COVID-19, but not for adults 50 to 64. Hepatologists explain what clinicians can do to close the gap.
October 01, 2026
As drinking declines, Stevan Gonzalez, MD, Frances Lee, MD, and Brian Lee, MD, on the lingering burden of alcohol-associated liver disease.
September 30, 2026
Heavy drinking rose >36% since 2018 among middle-aged adults. A hepatologist on screening, sex-specific thresholds, and pandemic effects.
Preview the biggest anticipated FDA decisions of Q4 2026, including bepirovirsen for CHB, obinutuzumab for pMN, bezuclastinib for systemic mastocytosis, and more.
September 28, 2026
Video
Ochsner Health uses multidisciplinary clinics, living donor programs, and transplant innovations to address access challenges.
Ochsner Transplant Institute director discusses liver transplant care, robotic kidney transplant, organ preservation, and access gaps.
Mirum's antibody led to virologic response and ALT normalization in up to 56% of patients at week 24, vs 0% with delayed treatment.
September 25, 2026
An Ochsner transplant surgeon discusses 10,000 transplants and how new tools are expanding who can receive an organ.
September 22, 2026
Frances Lee, MD, on the stigma driving under-detection of ALD and its disproportionate rise in women and younger adults.
September 21, 2026
Frances Lee, MD, on stigma's role in ALD care and why women may progress to advanced disease faster than men.